Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expression.

Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expression.

<h4>Background</h4>The response to cytotoxic chemotherapy varies greatly in patients with advanced non-small cell lung cancer (NSCLC), and molecular markers may be useful in determining a preferable therapeutic approach for individual patients. This retrospective study was performed to e...

Full description

Bibliographic Details
Main Authors:	Xiaopeng Dong, Yingtao Hao, Yucheng Wei, Qiuwei Yin, Jiajun Du, Xiaogang Zhao
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24647522/?tool=EBI

Similar Items

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.
by: Ioannis Boukovinas, et al.
Published: (2008-01-01)

Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
by: Yaqiong Zhan, et al.
Published: (2021-01-01)

Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer
by: Jiawei TIAN, et al.
Published: (2015-06-01)

Relations between RRM1 Protein Expression Levels and Effects of Gemcitabine and Cisplatin Chemotherapy in Advanced Non-small Cell Lung Cancer Patients
by: Zhiqiang GAO, et al.
Published: (2011-04-01)

RRM1 expression and the clinicopathological characteristics of patients with non-small cell lung cancer treated with gemcitabine
by: Chen Y, et al.
Published: (2018-09-01)

Clinical Significance of ERCC1, RRM1 and TS in Non–small Cell Lung Cancer
by: Pei LI, et al.
Published: (2014-06-01)

Os genes ERCC1 e RRM1 no carcinoma broncopulmonar ERCC1 and RRM1 genes in lung cancer
by: Lina Carvalho, et al.
Published: (2009-08-01)

The Changes of the first-line Chemotherapy on Advanced non-small Cell Lung Cancer
by: Baohui HAN, et al.
Published: (2008-04-01)

Gemcitabine in RRM1-negative Advanced Refractory  Non-small Cell Lung Cancer (NSCLC): A Case Report
by: Meiling ZHAO, et al.
Published: (2011-06-01)

Rechallenge with First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer
by: Toshihiro Shiozawa, et al.
Published: (2018-09-01)

Effects of Expression of ERCC1, RRM1 on Survival Trend of Lung Cancer with Cisplatin Combine Gemcitabine Chemotherapy after Surgical Resection
by: Min SONG, et al.
Published: (2009-05-01)

Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided 125I Seed Implantation vs. Second-Line Chemotherapy
by: Hao Wang, et al.
Published: (2020-04-01)

Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer
by: Fei Zhou, et al.
Published: (2020-07-01)

LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2
by: Na Huang, et al.
Published: (2019-10-01)

expression of RRM1 in cancer cells
by: Ya-Wen Hung, et al.
Published: (2013)

Analysis of the relationship between the response after the First-line chemotherapy and the survival in the advanced non-small cell lung cancer
by: Liping LIN, et al.
Published: (2008-06-01)

Effect of irinotecan combined with platinum first-line chemotherapy on brain metastasis of small cell lung cancer
by: CHEN Weiling, et al.
Published: (2020-03-01)

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer
by: Courèche-Guillaume Kaderbhai, et al.
Published: (2017-09-01)

First-line Chemotherapy for Extensive-disease Small Cell Lung Cancer:  A Network Meta-analysis
by: Yujie CHEN, et al.
Published: (2016-04-01)

The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report
by: Nikolai A. Ognerubov, et al.
Published: (2021-08-01)

Retrospective Study of Hepatotoxicity of Gemcitabine （Gemzar®）as First-line Chemotherapy in Non-Small Cell Lung Cancer
by: Ying-Hui Wu, et al.
Published: (2005)

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
by: Huabin Hu, et al.
Published: (2020-09-01)

Prospective Clinical Study of Postoperative Individualized Adjuvant Chemotherapy for Patients with Non-Small-Cell Lung Cancer Based on mRNA Expression of the Molecular Markers RRM1, TUBB3, and ERCC1
by: Jingyao Li, et al.
Published: (2021-01-01)

Short‐Term Efficacy of Different First‐Line Chemotherapy Regimens for Advanced Non‐Small Cell Lung Cancer: A Network Meta‐Analysis
by: Bei‐Bei Zhang, et al.
Published: (2020-05-01)

First-line immune-checkpoint inhibitor plus chemotherapy chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis
by: Thierry Landre, et al.
Published: (2020-12-01)

Survival of an elderly patient with lung cancer treated with first-line chemotherapy
by: Oscar Augusto Quintana Blancos, et al.
Published: (2021-10-01)

Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis
by: Hao Chen, et al.
Published: (2020-10-01)

The study progress of second-line chemotherapy of small cell lung cancer
by: Qian MIAO, et al.
Published: (2008-08-01)

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
by: Yayi He, et al.
Published: (2021-02-01)

Impact of the Pretreatment or Posttreatment NLR and PLR on the Response of First Line Chemotherapy and the Outcomes in Patients with Advanced Non-small Cell Lung Cancer
by: Fumei YI, et al.
Published: (2018-06-01)

THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.
by: Deyan Davidov
Published: (2014-12-01)

Analysis of Correlation between TTF-1 and Sensitivity to First-line Chemotherapy and Prognosis in Patients with Small Cell Lung Cancer
by: Bingrui WANG, et al.
Published: (2020-07-01)

MicroRNA-520a Suppresses Pathogenesis and Progression of Non-Small-Cell Lung Cancer through Targeting the RRM2/Wnt Axis
by: Yi Xie, et al.
Published: (2021-01-01)

Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy
by: Leng Xue-Feng, et al.
Published: (2012-03-01)

Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy
by: Desirée Hao, et al.
Published: (2020-07-01)

Maintenance therapy with oral etoposide following first-line docetaxel-cisplatin chemotherapy in metastatic non-small cell lung cancer patients
by: Meiyu Fang, et al.
Published: (2012-09-01)

Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy
by: Li Qian, et al.
Published: (2021-04-01)

Effect of RRM proteins on the replication of influenza A virus
by: Shiao-Shun Yen, et al.
Published: (2014)

Zinc Binds to RRM2 Peptide of TDP-43
by: Andrey V. Golovin, et al.
Published: (2020-11-01)

First-line Chemotherapy and Its Survival Analysis of 394 Patients with Extensive-stage Small Cell Lung Cancer in a Single Institute
by: Manjiao MA, et al.
Published: (2014-01-01)